Monte Rosa Therapeutics, Inc. Share Price

Monte Rosa Therapeutics, Inc. Share Price

NASDAQ: GLUE | Small Cap
$11.04
+$0.18 (1.70%) Last updated on 29 Oct, 2026 | 20:39 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Monte Rosa Therapeutics, Inc. Stock Performance

Open
$11.05
Prev. Close
$10.86
Circuit Range
N/A
Day Range
$10.92 - $11.13
Year Range
$9.71 - $25.75
Volume
10,422
Average Traded
$11.04

Monte Rosa Therapeutics, Inc. Share Price Today

As of 29 October 2026, Monte Rosa Therapeutics, Inc.'s share price is $11.04. The stock opened at $11.05, compared to its previous close of $10.86. During today's trading session, Monte Rosa Therapeutics, Inc.'s share price traded between $10.92 and $11.13, with an average price of $11.03. Over the past 52 weeks, the stock has recorded a high of $25.75 and a low of $9.71. In terms of performance, Monte Rosa Therapeutics, Inc.'s share price has declined by 42.35% over the last six months and is down 14.15% on a year-on-year basis.

Monte Rosa Therapeutics, Inc. Share Price Chart

Line chart of the Monte Rosa Therapeutics, Inc. price trend over the selected period. The price rose overall, ranging from 10.94 to 11.22, ending at 11.04.
$10.92$11.13
L
Show Current Price
H

Monte Rosa Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$917.11M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.89
Revenue (TTM)
$123.67B
Return On Equity (TTM)
-33.06%
Profit Margin
-31.24%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-60.27%

Monte Rosa Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$12.77$2.78$4.21$8.97
Net Profit-$27.08-$46.14-$44.50-$43.40
Net Profit Margin-212.06%-1659.71%-1057.01%-483.84%
Income ChangeN/A-70.38%3.55%2.47%

Monte Rosa Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$75.62$123.67
Net Profit-$108.50-$135.35-$72.70-$38.63
Net Profit MarginN/AN/A-96.14%-31.24%
Income ChangeN/A-24.75%46.29%46.86%

About Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics Inc is a clinical-stage biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. The company has three programs in clinical development: MRT-6160, a VAV1-directed MGD for immune-mediated diseases; MRT-8102, a NEK7-directed MGD for inflammatory diseases driven by IL-6, and the NLRP3 inflammasome; and MRT-2359, a GSPT1-directed MGD for metastatic castration resistant prostate cancer (mCRPC).

Monte Rosa Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$12.04
$11.04
-7.46%
Sep 2026
$13.89
$11.93
-16.75%
Aug 2026
$16.73
$14.33
-13.31%
Jul 2026
$24.40
$16.53
-31.82%
Jun 2026
$19.73
$24.25
+23.01%
May 2026
$18.98
$19.71
+2.92%
Apr 2026
$16.89
$19.15
+16.48%
Mar 2026
$17.44
$16.44
-7.43%
Feb 2026
$20.65
$17.76
-13.47%
Jan 2026
$15.59
$20.52
+30.90%
Dec 2025
$15.91
$15.68
-3.23%
Nov 2025
$12.88
$16.20
+26.00%

GLUE Share Price FAQs